ALL |
Acute lymphoid leukemia |
HSPC |
Hematopoietic stem and progenitor cells |
AML |
Acute myeloid leukemia |
HUVEC |
Human umbilical vein endothelial cell |
BC |
Breast cancer |
LN |
Laminin |
BLC |
Bone lining cells |
LTC-IC |
long-term culture-initiating cell |
BM |
Bone marrow |
MSC |
Mesenchymal stem cell |
BMTE |
Bone and marrow tissue engineering |
MVs |
Microvessels |
CAR |
CXCL12-abundant reticular |
NP |
Nanoparticle |
CFU |
Colony forming unit |
PCL |
Polycaprolactone |
CLL |
Chronic lymphoid leukemia |
PDMS |
Polydimethylsiloxane |
CML |
Chronic myeloid leukemia |
PEG |
Polyethylene glycol |
COL |
Collagen |
PEGDA |
Polyethylene (glycol) Diacrylate |
CRC |
Colorectal cancer |
PLA |
Poly-L-lactic acid |
CS |
Chitosan |
PLAGA |
Poly (lactic acid -co-glycolic acid) |
EBM |
Engineered bone marrow |
PLGA |
Poly(lactide-co-glycolide) copolymer |
ECM |
Extracellular matrix |
PRP |
Platelet rich plasma |
ESC |
Embryonic stem cell |
PVA |
Polyvinyl alcohol |
FN |
Fibronectin |
ROS |
Reactive oxygen species |
GAG |
Glycosaminoglycan |
SEM |
Scanning electron microscope |
HA |
Hydroxyapatite |
SCF |
Stem cell factor |
HCs |
Hematological cancers |
SDF1 |
Stromal derived factor 1 |
HCTE |
Hematological cancer tissue engineering |
TCPS |
Tissue culture polystyrene |
hiPSC |
Human induced pluripotent stem cell |
TE |
Tissue engineering |
HPC |
Hematopoietic progenitor cell |
TEB |
Tissue engineered bone |
HSC |
Hematopoietic stem cell |
|
|